Environmental Wipe Sampling Testing
One Swab.
Multiple Analytes.
One Clear Answer.
Screen broadly for hazardous drug residue in a single sample. Our panel method using liquid chromatography–tandem mass spectrometry – LC-MS/MS, detects multiple analytes per swab, with sensitivity down to 0.1 ng/mL for select compounds, so your monitoring program covers more ground, faster, and supports your USP <800> compliance goals.
Environmental Wipe Testing | LC-MS/MS Panel Method
One Swab.
Multiple Analytes.
One Clear Answer.
Screen broadly for hazardous drug residue in a single sample. Our LC-MS/MS panel method detects multiple analytes per swab, with sensitivity down to 0.1 ng/mL for select compounds, so your monitoring program covers more ground, faster, and supports your USP <800> compliance goals.
Coverage
What we test for
Our panel covers commonly monitored hormones, chemotherapy agents, and other hazardous and non-hazardous drugs encountered across compounding, dispensing, and administration settings. Each analyte is tested using validated methodology suited to its detection requirements, using either our Panel or Targeted method.
Hormones
Estradiol, Estriol, Estrone, Ethinyl Estradiol, DHEA, Hydroxyprogesterone, Methyltestosterone, Progesterone, Testosterone, Testosterone Cypionate, Testosterone Propionate.
Chemotherapy Drugs
5-Fluorouracil, Busulfan, Carboplatin, Cisplatin, Cyclophosphamide, Cytarabine, Daunorubicin, Docetaxel, Doxorubicin, Etoposide, Gemcitabine, Ifosfamide, Irinotecan, Methotrexate, Oxaliplatin, Topotecan, Vinblastine, Vincristine.
Hazardous Drugs
Apomorphine, Azathioprine, Chloramphenicol, Colchicine, Finasteride, Fluconazole, Methimazole, Oxytocin, Spironolactone, Tamoxifen Citrate, Tretinoin, Zonisamide.
Non-Hazardous Drugs
Ascorbic Acid, Tadalafil.
Looking for a drug not listed here? Get in touch and we’ll discuss it.
Hormones:
Estradiol, Estriol, Estrone, Ethinyl Estradiol, DHEA, Hydroxyprogesterone, Methyltestosterone, Progesterone, Testosterone, Testosterone Cypionate, Testosterone Propionate.
Chemotherapy Drugs:
5-Fluorouracil, Busulfan, Carboplatin, Cisplatin, Cyclophosphamide, Cytarabine, Daunorubicin, Docetaxel, Doxorubicin, Etoposide, Gemcitabine, Ifosfamide, Irinotecan, Methotrexate, Oxaliplatin, Topotecan, Vinblastine, Vincristine.
Hazardous Drugs:
Apomorphine, Azathioprine, Chloramphenicol, Colchicine, Finasteride, Fluconazole, Methimazole, Oxytocin, Spironolactone, Tamoxifen Citrate, Tretinoin, Zonisamide.
Non-Hazardous Drugs:
Ascorbic Acid, Tadalafil.
Best for broad monitoring
Panel Method
Screen for multiple hazardous drug analytes from a single swab using LC-MS/MS – ideal for routine, facility-wide baseline monitoring
Analytes per swab Multiple
Instrument LC-MS/MS
Best for Broad, routine screening
Best for focused follow-up
Targeted method
Confirm a single analyte at one specific location using UPLC – ideal when you already know what you’re investigating
Analytes per swab One
Instrument UPLC
Best for Investigation, verification
Eagle’s Approach
Our ways to test
We offer two validated methods for environmental swab testing. Although the methods use different instruments, they are fundamentally similar in purpose and application. We understand that every partner may have different needs, which is why we offer two options to choose from. Both methods are ideal for routine, facility-wide monitoring, especially when you already know what you’re investigating. If you’re unsure which method is right for your needs, please contact us – we’re happy to help.
Panel Testing
Multiple Analytes from One Swab
Screen for multiple drug analytes from a single swab collected from one location
Analytes per swab Multiple
Instrument LC-MS/MS
Sensitivity (LOD) as low as 0.1 ng/mL for select analytes
Result Format: Quantitative + Qualitative
Single Analyte Testing
Targeted Testing for One Analyte
Test one known marker drug per swab from a defined sampling location
Analytes per swab One
Instrument UPLC
Sensitivity (LOD) as low as 1 ng/mL
Result Format: Quantitative + Qualitative
One Timeline for Both Methods
Turnaround Time (TAT)
Panel Method:
Standard Turnaround Time: 5 Days
Rush Turnaround Time: 3 Days
Method Suitability Turnaround Time: 1 month
Single Analyte method:
Standard Turnaround Time: 5 Days
Rush Turnaround Time: 3 Days
Method Suitability Turnaround Time: 1 month
How Do We Report Results
Detection at the level that matters
Results are typically reported in ng/swab or, when concentrations are higher, µg/swab. You can calculate results in ng/cm² based on the sampled area. Because not all sampling locations can accommodate a 100 cm² template, the actual sample size should be used for this calculation. Results below the applicable detection or quantitation limit are reported as < LOD or < LOQ, along with the corresponding LOD or LOQ value.
ng/swab or µg/swab
for Higher Concentrations
LOD/ LOQ
Limits Available on Request
EagleTrax
Trend Data in Online Portal
0.1 ng/mL
For Select Compounds
Customizable, easy to use, and ready to ship – order the sampling kit that gets your swab to our lab.
Start Sampling
Every wipe test starts with a SurfaceShield Kit
Sampling Process
Where & When to sample
◆ Receipt / Storage
Containers, storage floors, shelves, walls
◆ Compounding
Hood, adjacent surfaces, staging & weighing areas
◆ Dispensing
Counter-tops, keyboards, drug containers
◆ Administration
Preparation area, bedside equipment
◆ Transport
Carts
◆ Disposal
Shelves, waste containers, floors and walls
◆ EagleTrax
Build, Track, and Trend Swab Testing Submissions
Track every submission and trend results over time in EagleTrax and monitor trends over time using Shield Analysis tool.
Watch our video guide to learn how to build a submission for swab testing.
Frequently Asked Questions
Before you reach out
We can provide simple support at no cost; anything more involved will require a consulting arrangement.
The sample submissions and test results can be tracked in real time in our online portal EagleTrax.
Through our sample submission system, EagleTrax, you will have access to Shield Analysis, a feature that allows you to trend results over time. An important consideration is that your sample information must be standardized at the time of submission.